Professor Lisa Keay is Head of the School of Optometry and Vision Science and an Honorary Professorial Fellow at The George Institute for Global Health. She has developed links with government, community organisations and other stakeholders to identify key, policy-relevant research questions and to answer them with high quality research.  Her research tackles the two major causes of injury to older people: falls and road traffic injuries.

She is an injury epidemiologist with a PhD in ophthalmic epidemiology and Masters of Public Health University of NSW Wales and a post-doctoral research fellowship from Johns Hopkins University.

Manoj continues to practise as an Intensive Care Physician and is based part-time at St. George Public Hospital in Sydney, playing a key role in the intensive care research program with Professor John Myburgh. He is also a Conjoint Lecturer at the Faculty of Medicine, UNSW.

His postgraduate qualifications include Fellowship of both the Royal College of Physicians in the United Kingdom and Australia and Fellowship of the College of Intensive Care Medicine.

Research interests include large scale clinical observational and randomised trials. Further specific areas of research interest include the role of fever in severe infections and acute brain injury, Intensive Care Unit Acquired Weakness and Early Mobility, and Outcome Evaluation in Critical Care Medicine research.

Manuela is the Senior Clinical Data Manager for the Statistics and Data Management division of The George Institute, Australia.

Professor Ferreira is NHMRC Investigator Fellow, Professor of Musculoskeletal Health and Program Head, Musculoskeletal Health, at The George Institute for Global Health, where she conducts research on the mechanisms, prognosis and management of musculoskeletal disorders with a focus on low back pain. Before joining The George Institute, she was Professor of Musculoskeletal Health at the University of Sydney, where she was inaugural chair of the Musculoskeletal Priority Research Area (+80 researchers) at the Kolling Institute, and co-chair of the Musculoskeletal Clinical Advisory Group of Sydney Health Partners (an NHMRC, Sydney University and health district research translation partnership). With +320 scientific publications, and +AUD30M in research funding, she is the 2nd highest ranked researcher in the world for ‘low back pain’ (of a total of 33,000 authors worldwide – Expertscape). She currently leads multiple randomised controlled trials of musculoskeletal interventions, including the first placebo randomised controlled trial of spinal surgery, an NHMRC-funded study that will establish the efficacy of decompressive surgery for lumbar spinal stenosis. 

Maree is responsible for designing, leading, and delivering a distinctive and vibrant postgraduate, postdoctoral and future leader research experience at The George. Maree and her team provide management and oversight of ‘higher degree by research’ candidates, their supervisors, visiting fellows and work with the training team to co-ordinate postgraduate research training.

Maree also leads a program of research focusing on developing simple, cost-effective strategies to prevent depression and significantly improve the outcome for people with chronic disease.

Maree works one day per week as a Professor of Epidemiology in the Faculty of Health and Wellbeing at The University of Central Lancashire in the United Kingdom.

Martin is Professorial Fellow at the George Institute, Head of the South Western Sydney Campus for the Faculty of Medicine & Health at UNSW, and a clinical nephrologist at Liverpool Hospital.

He has worked extensively within the ANZ Society of Nephrology in renal guidelines, clinical policy and research.

Martin’s research interests include large scale clinical trials to explore ways to improve the outcomes of patients with kidney disease (esp in the setting of acute kidney injury), measurement of health systems and applying research evidence into clinical practice.

Dr Land is a Senior Program Manager at The George Institute for Global Health, where she leads global initiatives to transition the world’s salt supply to potassium-enriched alternatives. This work addresses the urgent global challenge of high sodium intake and its associated health risks, advancing innovative strategies to improve cardiovascular health worldwide.

Prior to her current role, Dr Land held several key positions at the World Health Organization. Including playing a crucial role in the development and implementation of the highly successful global cervical cancer elimination program. Her leadership and strategic expertise were instrumental in advancing the initiative forward, securing essential support and securing commitments for its implementation.

With a robust background in both hands-on program implementation and high-level advisory roles, Dr Land continues to shape and advance global health policies and practices.

A/Professor Meg Jardine is a Honorary Professorial Fellow at The George Institute for Global Health.

Her research interests centre on preventing the progression and complications of kidney disease and diabetes. She has a particular interest in using innovative trial designs to better generate evidence to improve outcomes. Dr Jardine leads the RESOLVE and BEAT-Calci trials and was the Global Scientific Lead of the CREDENCE study and CI of the ACTIVE and FINESSE trials. Her advocacy for kidney disease is pursued through memberships of the Board of the Kidney Health Initiative (KHI), the Executive Committee of the international KDIGO guidelines group and the International Society of Nephrology Advancing Clinical Trials (ISN-ACTS) core committee. 

Meg Jardine is a practising physician and nephrologist at Concord Repatriation General Hospital

Associate Professor Naomi Hammond is an internationally recognised critical care and sepsis nurse research leader. She heads the Critical Care and Sepsis Australia Programs at The George Institute for Global Health and serves as Executive Director of Research for Northern Sydney Local Health District in Sydney, Australia. Naomi holds multiple academic and leadership appointments, including Honorary Professorial Nurse Research Fellow in the Malcolm Fisher Department of Intensive Care Medicine at Royal North Shore Hospital, NHMRC Emerging Leader Fellow, Conjoint Associate Professor at UNSW Medicine & Health, Treasurer of the Asia Pacific Sepsis Alliance, and Chair of the Australian Critical Care Nurses Research Advisory Panel.

With over $30 million AUD in competitive research funding (including over $8 million AUD as CIA), Naomi has successfully led national and international research programs and multidisciplinary teams across healthcare and academic settings. She has collaborated and led research that has resulted in more than 200 peer-reviewed publications, including in NEJM, NEJM Evidence, JAMA, and Intensive Care Medicine. She has been recognised as Australia’s leading researcher in Critical Care by The Australian Research Magazine in 2024, 2025 and 2026. Her work focuses on improving outcomes for sepsis and critically ill people through evidence-based interventions.
 

Pallab leads Research department at The George Institute for Global Health, India. He trained as a psychiatrist at All India Institute of Medical Sciences, New Delhi, received training in public health at the London School of Hygiene and Tropical Medicine, as well as Johns Hopkins School of Public Health where he pursued his Masters and Doctoral training, respectively.

Professor Maulik has worked with the World Health Organisation (WHO), Geneva on Project Atlas and other mental health programs, and clinically as a psychiatrist in India and Australia. He has worked for more than 25 years in global mental health and has research network across multiple countries and institutions where he is affiliated with and with whom he collaborates on many projects.  

His particular research interests include social determinants of health, especially mental health services, mental disorders, international mental health, and intellectual disability. He is a Principal Investigator or co-investigator on many large mental health projects in India and abroad. He primarily focuses on delivering affordable and accessible mental health care for disadvantaged and marginalized communities in India, while using technology-enabled solutions to enable the health system to function more efficiently. He also leads a significant programme of work on stigma related to mental health. He was an Intermediate Career Wellcome Trust/DBT India Alliance Fellow from 2014-19 and currently is a Senior Fellow of the Wellcome Trust/DBT India Alliance.

Dr Parisa Glass is the Director of Innovation and Enterprise for The George Institute for Global Health. In this role, she leads Health 10x Accelerator in partnership with UNSW Sydney. Health 10x accelerator supports startups developing affordable and scalable solutions to some of the most pressing unmet medical needs, globally. 

Parisa also leads UNSW Clinical Research Unit (CRU) which is collaborative program with The George Institute. UNSW CRU supports clinical researchers across UNSW network with operational and academic expertise, systems and tools to conduct high quality and impactful research efficiently and in accordance with best practice guidelines.  

Parisa has a PhD in Biomedical Science and a Masters Degree in Business Administration (MBA). Parisa also holds a Senior Lecturer position with UNSW Sydney.

Parisa joined The George Institute for Global Health in 2008. She has over twenty years’ experience in health and university sectors in an operational and academic capacity. Her expertise is in operational leadership & optimisation, strategic planning, coaching & mentoring, managing change, financial management, program development and management, contract negotiations, stakeholder management and recruiting and developing top talent.

Qiang is Lead Biostatistician in Statistics Division at the George Institute and Conjoint Associate Professor at The University of New South Wales. He has a master degree in Biostatistics from the University of Sydney and a Bachelor degree in Public Health (Preventive Medicine) from Xi'an JiaoTong University (China). He is an accredited statistician by the Statistical Society of Australia since 2009. 

Prior to joining the George Institute in 2007, Qiang worked at the Woolcock institute of medical research (Australia) for one year and at the School of Public Health in Xi'an JiaoTong University (China) for six years. In his current position, Qiang Li is responsible for the design, analysis and reporting of numerous medical studies ranging from health surveys and epidemiological studies to multinational clinical trials in critical care, cardiovascular diseases, neurological and mental health illnesses, renal and metabolic diseases. In 19 years at the George Institute, he has worked on numerous major research studies including NHMRC funded studies as well as a number of clinical trials sponsored by the pharmaceutical industry.